Koala Vaccine Efficacy Questioned by Researchers

A recently approved koala vaccine faces scrutiny following the identification of a significant data error in a supporting study. Researchers from the University of Queensland and University of Sydney have raised concerns that a "silly mistake" in data analysis may have incorrectly attributed survival rates to the vaccine, potentially overstating its efficacy. A pre-print review suggested that after correcting the error, there was no significant difference in survival or disease rates between vaccinated and unvaccinated koalas.

Despite these findings, the Australian Pesticides and Veterinary Medicines Authority (APVMA), the veterinary medicines regulator, stated that it does not consider issuing the permit a regulatory failure. The APVMA maintains that the permitted claim, "may aid in the reduction of clinical signs of the disease," is qualified and limited. They emphasize that all credible scientific information will be assessed to determine if regulatory action is warranted.

University of the Sunshine Coast (UniSC) researchers, who developed the single-dose vaccine, welcome scientific scrutiny. They acknowledge that disagreements are common in active research areas and assert that this debate does not invalidate over a decade of peer-reviewed science supporting vaccine development for koala chlamydia. A separate randomized controlled trial in New South Wales did show the vaccine stimulated an immune response but did not translate to a reduction in chlamydiosis.